These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 33115871)

  • 21. Intranasal administration of octavalent next-generation influenza vaccine elicits protective immune responses against seasonal and pre-pandemic viruses.
    Uno N; Ebensen T; Guzman CA; Ross TM
    J Virol; 2024 Sep; 98(9):e0035424. PubMed ID: 39171925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin.
    Sautto GA; Kirchenbaum GA; Abreu RB; Ecker JW; Pierce SR; Kleanthous H; Ross TM
    J Immunol; 2020 Jan; 204(2):375-385. PubMed ID: 31811019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COBRA HA and NA vaccination elicits long-live protective immune responses against pre-pandemic H2, H5, and H7 influenza virus subtypes.
    Ge P; Ross TM
    Virology; 2024 Sep; 597():110119. PubMed ID: 38850895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Next-Generation H3 Influenza Vaccines in Ferrets Pre-Immune to Historical H3N2 Viruses.
    Allen JD; Ross TM
    Front Immunol; 2021; 12():707339. PubMed ID: 34475872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivated influenza virus vaccines expressing COBRA hemagglutinin elicited broadly reactive, long-lived protective antibodies.
    Shi H; Zhang X; Ge P; Meliopoulos V; Freiden P; Livingston B; Schultz-Cherry S; Ross TM
    Hum Vaccin Immunother; 2024 Dec; 20(1):2356269. PubMed ID: 38826029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses.
    Allen JD; Ray S; Ross TM
    PLoS One; 2018; 13(9):e0204284. PubMed ID: 30265682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Pre-Pandemic Trivalent COBRA HA Vaccine in Mice Pre-Immune to Historical H1N1 and H3N2 Influenza Viruses.
    Ge P; Ross TM
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mastoparan-7 adjuvanted COBRA H1 and H3 hemagglutinin influenza vaccines.
    Sanchez PL; Staats HF; Abraham SN; Ross TM
    Sci Rep; 2024 Jun; 14(1):13800. PubMed ID: 38877101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection.
    Giles BM; Crevar CJ; Carter DM; Bissel SJ; Schultz-Cherry S; Wiley CA; Ross TM
    J Infect Dis; 2012 May; 205(10):1562-70. PubMed ID: 22448011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
    Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination.
    Wei CJ; Boyington JC; McTamney PM; Kong WP; Pearce MB; Xu L; Andersen H; Rao S; Tumpey TM; Yang ZY; Nabel GJ
    Science; 2010 Aug; 329(5995):1060-4. PubMed ID: 20647428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in the Hemagglutinin Stalk Domain Do Not Permit Escape from a Protective, Stalk-Based Vaccine-Induced Immune Response in the Mouse Model.
    Roubidoux EK; Carreño JM; McMahon M; Jiang K; van Bakel H; Wilson P; Krammer F
    mBio; 2021 Feb; 12(1):. PubMed ID: 33593972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.
    Isakova-Sivak I; de Jonge J; Smolonogina T; Rekstin A; van Amerongen G; van Dijken H; Mouthaan J; Roholl P; Kuznetsova V; Doroshenko E; Tsvetnitsky V; Rudenko L
    PLoS One; 2014; 9(7):e102339. PubMed ID: 25058039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains.
    Ross TM; DiNapoli J; Giel-Moloney M; Bloom CE; Bertran K; Balzli C; Strugnell T; Sá E Silva M; Mebatsion T; Bublot M; Swayne DE; Kleanthous H
    Vaccine; 2019 Apr; 37(17):2369-2376. PubMed ID: 30905528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Improved Inactivated Influenza Vaccine with Enhanced Cross Protection.
    Ni Y; Guo J; Turner D; Tizard I
    Front Immunol; 2018; 9():1815. PubMed ID: 30140267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elicitation of Broadly Protective Antibodies following Infection with Influenza Viruses Expressing H1N1 Computationally Optimized Broadly Reactive Hemagglutinin Antigens.
    Sautto GA; Kirchenbaum GA; Ecker JW; Bebin-Blackwell AG; Pierce SR; Ross TM
    Immunohorizons; 2018 Aug; 2(7):226-237. PubMed ID: 31022693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
    Kwon HI; Kim YI; Park SJ; Song MS; Kim EH; Kim SM; Si YJ; Lee IW; Song BM; Lee YJ; Yun SJ; Kim WJ; Choi YK
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.